Literature DB >> 19850502

Psychosocial adjustment in siblings of young people with Duchenne muscular dystrophy.

Joy Read1, Maria Kinali, Francesco Muntoni, M Elena Garralda.   

Abstract

Duchenne muscular dystrophy (DMD) is a progressive, impairing, life-limiting disorder of childhood. Little is known about how siblings adapt to this. The aim of this study is to document psychosocial adjustment in siblings of patients with DMD. Healthy siblings (11-18 years old) of young people with DMD attending a specialist paediatric centre and their parent/main carer took part. Parents, siblings and teachers completed a battery of questionnaires: (i) to assess psychiatric risk the Strengths and Difficulties Questionnaire (SDQ), General Health Questionnaire (GHQ), Hospital Anxiety and Depression Scale (HADS); (ii) to measure general wellbeing: SF-36; (iii) to document DMD illness disability: Functional Disability Inventory (FDI); (iv) to assess family function and life stresses for the unaffected sibling: Family Assessment Device (FAD), Family Burden Interview Schedule and Life Events Checklist. Forty six/77 eligible siblings (24 females/22 males); (mean age 14 years (SD 2.3)) took part. Although their mean psychological functioning and wellbeing questionnaire scores were comparable to normative data, there was a trend for more siblings scoring at high-risk for psychological (mainly emotional) problems. Weak/moderate associations with psychological symptoms in siblings varied according to informant and included the following factors: closeness in age to the affected sibling; older sibling age; extent of wheelchair use, burden of illness on family interactions, and siblings reporting high impact of illness on their lives. Psychological symptoms were also associated with less sibling involvement in patient care, with broader psychosocial and family disadvantage and with life stresses. Siblings have an increased risk for emotional problems, which appears influenced by specific illness factors. Copyright (c) 2009 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19850502     DOI: 10.1016/j.ejpn.2009.09.011

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  12 in total

1.  Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls.

Authors:  Jamie L Jackson; Christina X Korth; Carine E Leslie; Jennifer Cotto; May Ling Mah; Kan Hor; Linda Cripe; Samiah Al-Zaidy; Eric M Camino; Kathleen Church; Kelly J Lehman; Victoria Shay; Jerry R Mendell
Journal:  J Child Neurol       Date:  2020-10-09       Impact factor: 1.987

2.  Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study.

Authors:  Lorenza Magliano; Maria Grazia D'Angelo; Giuseppe Vita; Marika Pane; Adele D'Amico; Umberto Balottin; Corrado Angelini; Roberta Battini; Luisa Politano; Melania Patalano; Alessandra Sagliocchi; Federica Civati; Erika Brighina; Gian Luca Vita; Sonia Messina; Maria Sframeli; Maria Elena Lombardo; Roberta Scalise; Giulia Colia; Maria Catteruccia; Angela Berardinelli; Maria Chiara Motta; Alessandra Gaiani; Claudio Semplicini; Luca Bello; Guja Astrea; Antonella Zaccaro; Marianna Scutifero
Journal:  Acta Myol       Date:  2014-12

Review 3.  Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta.

Authors:  Maman Joyce Dogba; Frank Rauch; Erin Douglas; Christophe Bedos
Journal:  Health Qual Life Outcomes       Date:  2014-10-25       Impact factor: 3.186

4.  Psychological wellbeing and quality-of-life among siblings of paediatric CFS/ME patients: A mixed-methods study.

Authors:  Sophie Velleman; Simon M Collin; Lucy Beasant; Esther Crawley
Journal:  Clin Child Psychol Psychiatry       Date:  2015-09-22       Impact factor: 2.544

5.  Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions.

Authors:  Luisa Politano; Marianna Scutifero; Melania Patalano; Alessandra Sagliocchi; Antonella Zaccaro; Federica Civati; Erika Brighina; Gianluca Vita; Sonia Messina; Maria Sframeli; Maria Elena Lombardo; Roberta Scalise; Giulia Colia; Maria Catteruccia; Angela Berardinelli; Maria Chiara Motta; Alessandra Gaiani; Claudio Semplicini; Luca Bello; Guja Astrea; Giulia Ricci; Maria Grazia D'Angelo; Giuseppe Vita; Marika Pane; Adele D'Amico; Umberto Balottin; Corrado Angelini; Roberta Battini; Lorenza Magliano
Journal:  Acta Myol       Date:  2017-03

6.  Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives.

Authors:  Michelle A Farrar; Kate A Carey; Sarah-Grace Paguinto; Georgina Chambers; Nadine A Kasparian
Journal:  BMJ Open       Date:  2018-05-24       Impact factor: 2.692

7.  Psychosocial Functioning in Siblings of Children With Rare Disorders Compared to Controls.

Authors:  Yngvild B Haukeland; Torun M Vatne; Svein Mossige; Krister W Fjermestad
Journal:  Yale J Biol Med       Date:  2021-12-29

8.  The experiences of patients with Duchenne muscular dystrophy in facing and learning about their clinical conditions.

Authors:  Haruo Fujino; Yuko Iwata; Toshio Saito; Tsuyoshi Matsumura; Harutoshi Fujimura; Osamu Imura
Journal:  Int J Qual Stud Health Well-being       Date:  2016-10-05

Review 9.  The Role of Resilience in the Sibling Experience of Pediatric Palliative Care: What Is the Theory and Evidence?

Authors:  Wei Ling Chin; Tiina Jaaniste; Susan Trethewie
Journal:  Children (Basel)       Date:  2018-07-16

10.  Understanding the Global Challenges to Accessing Appropriate Wheelchairs: Position Paper.

Authors:  Rosemary Joan Gowran; Nathan Bray; Mary Goldberg; Paula Rushton; Marie Barhouche Abou Saab; David Constantine; Ritu Ghosh; Jonathan Pearlman
Journal:  Int J Environ Res Public Health       Date:  2021-03-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.